Target intelligence / Profile preview

ATP-sensitive potassium channel sulfonylurea receptor subunit (SUR) (SUR)

Target
SUR
Molecular classification
ATP-binding cassette transporter, Ion channel regulatory subunit, Receptor
01

Overview

The ATP-sensitive potassium (K_ATP) channel sulfonylurea receptor (SUR) subunit is a critical regulatory component of the K_ATP channel complex, which couples cellular metabolic status to membrane excitability [1, 5]. It belongs to the ATP-binding cassette (ABC) transporter superfamily and exists in two primary forms: SUR1 (encoded by ABCC8), predominantly found in pancreatic beta cells and neurons, and SUR2 (encoded by ABCC9), found in cardiac, skeletal, and smooth muscle [1, 8, 12]. By sensing the intracellular ATP/ADP ratio, the SUR subunit modulates the opening and closing of the pore-forming Kir6.x subunits [5, 13]. In pancreatic beta cells, an increase in the ATP/ADP ratio leads to channel closure, triggering membrane depolarization and insulin secretion [5, 18]. This mechanism makes the SUR subunit a primary therapeutic target for metabolic disorders; sulfonylurea drugs and meglitinides inhibit the receptor to stimulate insulin release in type 2 diabetes, while potassium channel openers like diazoxide activate it to treat hyperinsulinism [3, 9, 10]. Mutations in the SUR subunits are linked to various genetic conditions, including neonatal diabetes, congenital hyperinsulinism, and Cantú syndrome [12, 16, 19].

Other names
SURSUR1SUR2ABCC8ABCC9Sulfonylurea receptor 1Sulfonylurea receptor 2ATP-binding cassette sub-family C member 8ATP-binding cassette sub-family C member 9ABC36ABC37PHHIHHF1
02

Mechanism of action

Sulfonylureas and meglitinides bind to the SUR subunit, inhibiting the K_ATP channel, which leads to membrane depolarization and insulin secretion. Potassium channel openers bind to the SUR subunit to stabilize the open state of the channel, causing hyperpolarization and inhibiting cellular activity [3, 9, 10].

03

Biological functions

Insulin secretionGlucose homeostasisMetabolic sensingMembrane potential regulationVasodilationCardioprotection
04

Disease associations

Type 2 diabetes mellitusNeonatal diabetesCongenital hyperinsulinismCantú syndromeCardiovascular diseaseHyperinsulinemic hypoglycemia
05

Safety considerations

HypoglycemiaWeight gainCardiovascular risksSecondary failure of beta cells
06

Interacting drugs

Glibenclamide

9 more in the full profile.

07

Biomarkers

Blood glucoseHbA1cC-peptideInsulin levelsABCC8 mutationABCC9 mutation

Beyond the preview

Go deeper on ATP-sensitive potassium channel sulfonylurea receptor subunit (SUR) (SUR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-sensitive potassium channel sulfonylurea receptor subunit (SUR) (SUR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call